交易 ClearPoint Neuro Inc - CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company''s product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Microsystems, LLC, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Irvine, California.最新股票文章

台積電股價預測:第三方目標價
台灣積體電路製造公司(TSM)在2025年9月25日UTC下午4時55分報276.65美元,盤中區間介於270.91美元至282.95美元之間。
08:56, 3 11月 2026

IonQ 股價預測:第三方目標價
IonQ 開發囚禁離子量子系統,2026 年第一季調整後 EBITDA 虧損 9,680 萬美元,同時致力打造 256 量子位元系統。探索第三方 IONQ 目標價與技術分析。過往表現並非未來結果的可靠指標。
09:45, 30 10月 2026

Uber Technologies 股價預測:裁減 3,300 個職位,拓展機械人計程車業務
Uber 正進行重組,裁減約 3,300 個職位,同時在機械人計程車市場競爭加劇之際,擴大自動駕駛汽車合作關係。本文整理第三方對 UBER 的股價目標及技術分析。過往表現並非未來業績的可靠指標。
10:51, 2 10月 2026
